Related Experiment Video
Updated: Aug 2, 2026
10:04
Quantification of Cerebral Vascular Architecture using Two-photon Microscopy in a Mouse Model of HIV-induced Neuroinflammation
Published on: January 12, 2016
Neurocognitive disorders seen in HIV disease
P J Ungvarski1, H Trzcianowska
1Visiting Nurse Service of New York, New York 10001, USA. PUNGVARS@mail1.VNSNY.org
Issues in Mental Health Nursing
|June 6, 2000
Summary
Human immunodeficiency virus (HIV) disease can cause cognitive disorders despite treatment advances. Understanding the diverse causes of HIV-related cognitive impairment is crucial for effective management.
Area of Science:
- Neuroscience
- Infectious Diseases
- Clinical Medicine
Background:
- Despite therapeutic advancements for human immunodeficiency virus (HIV) disease, cognitive disorders remain a significant clinical manifestation.
- Neuro-cognitive impairment in HIV is linked to high viral activity and severe immunosuppression.
- HIV-related cognitive dysfunction encompasses more than just HIV encephalopathy and dementia.
Purpose of the Study:
- To elucidate the multifaceted etiologies of cognitive disorders in the context of HIV disease.
- To highlight the range of conditions contributing to cognitive impairment beyond direct HIV brain infection.
- To outline current and potential treatment strategies for HIV-associated neuro-cognitive dysfunction.
Main Methods:
- Review of existing literature on HIV-associated neuro-cognitive disorders.
- Analysis of etiological factors including opportunistic infections, neoplasms, and iatrogenic effects.
- Synthesis of information on pharmacologic, complementary, and supportive care interventions.
Main Results:
- Cognitive impairment in HIV stems from diverse causes, including direct viral effects, co-infections, malignancies, and medication side effects.
- HIV encephalopathy and dementia are not the sole contributors to cognitive dysfunction.
- A comprehensive approach is necessary to address the varied causes of cognitive impairment.
Conclusions:
- Effective management of HIV-related cognitive disorders requires addressing a broad spectrum of potential causes.
- Integrated treatment strategies combining pharmacotherapy, alternative therapies, and environmental management are essential.
- Continued research is needed to fully understand and combat the neurological impact of HIV disease.
Related Concept Videos
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
01:27Cryptococcal Meningitis
Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:21Huntington Disease l: Introduction
Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...
01:29Hepatic Encephalopathy
DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...